New drug duo tested for Tough-to-Treat bile duct cancer
Disease control
Completed
This study tested a combination of two drugs, pembrolizumab and lenvatinib, for people with advanced bile duct cancer that had worsened despite standard chemotherapy. The goal was to see if this drug pair could help control the cancer and was safe for patients. It involved 27 par…
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC